{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T16:38:09Z","timestamp":1787330289534,"version":"build-2736575974"},"reference-count":25,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Takeda Pharmaceuticals USA, Inc."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2026,3,4]]},"DOI":"10.1080\/03007995.2026.2676335","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T20:11:47Z","timestamp":1779999107000},"page":"529-539","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Quantifying US healthcare provider preferences for the treatment of post-transplant cytomegalovirus infection using a discrete choice experiment"],"prefix":"10.1080","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3270-2010","authenticated-orcid":false,"given":"Zoe","family":"Raglow","sequence":"first","affiliation":[{"name":"University of Michigan","place":["Ann Arbor, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0990-4148","authenticated-orcid":false,"given":"Dan","family":"Kaul","sequence":"additional","affiliation":[{"name":"University of Michigan","place":["Ann Arbor, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6335-3223","authenticated-orcid":false,"given":"Ana Mar\u00eda","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"IQVIA","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5678-4137","authenticated-orcid":false,"given":"Ana Sofia","family":"Oliveira Gon\u00e7alves","sequence":"additional","affiliation":[{"name":"IQVIA","place":["Lisbon, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6444-4573","authenticated-orcid":false,"given":"Mickael","family":"Henry-Szatkowski","sequence":"additional","affiliation":[{"name":"IQVIA","place":["Courbevoie, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7728-2435","authenticated-orcid":false,"given":"France","family":"Ginchereau Sowell","sequence":"additional","affiliation":[{"name":"IQVIA","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9961-4576","authenticated-orcid":false,"given":"Michael","family":"Bullano","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceuticals USA, Inc","place":["Lexington, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2546-6341","authenticated-orcid":false,"given":"Daniele K.","family":"Gelone","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceuticals USA, Inc","place":["Lexington, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7023-8378","authenticated-orcid":false,"given":"Bob G.","family":"Schultz","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceuticals USA, Inc","place":["Lexington, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12006"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1302627"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2015(07)09"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piad059"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002191"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2022.2046388"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7248.1530"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta5050"},{"key":"e_1_3_7_10_1","first-page":"1","article-title":"Patient preference information \u2013 voluntary submission, review in premarket approval applications, humanitarian device exemption applications, and de novo requests, and inclusion in decision summaries and device labeling","author":"FDA","unstructured":"FDA. Patient preference information \u2013 voluntary submission, review in premarket approval applications, humanitarian device exemption applications, and de novo requests, and inclusion in decision summaries and device labeling. Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders. FDA-2015-D-1580;1\u201326.","journal-title":"Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.04.004"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.2165\/11539650-000000000-00000"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.08.2223"},{"key":"e_1_3_7_14_1","unstructured":"ChoiceMetrics. 2022. Cited 2025. Available from: http:\/\/www.choice-metrics.com\/index.html."},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab988"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.05.001"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-679639"},{"key":"e_1_3_7_18_1","first-page":"352","article-title":"Managing myelosuppression: strategies for optimal care in transplant patients","volume":"13","author":"Cole C.","year":"2024","unstructured":"Cole C. Managing myelosuppression: strategies for optimal care in transplant patients. Adv Pharmacoepidemiol Drug Saf. 2024;13:352.","journal-title":"Adv Pharmacoepidemiol Drug Saf"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000005374"},{"key":"e_1_3_7_20_1","author":"Ljungman P","unstructured":"Ljungman P, C\u00e1mara R, Alain S, et al. editors. CMV Recommendations ECIL-10 Final. 10th European Conference on Infections in Leukaemia; 9-21 September 2024; Nice, France.","journal-title":"CMV Recommendations ECIL-10 Final. 10th European Conference on Infections in Leukaemia"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00069-6"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2026.103788"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13521"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.05.007"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012854.pub2"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2019.1552256"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2026.2676335","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/03007995.2026.2676335","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2026.2676335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:55:56Z","timestamp":1787327756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2026.2676335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,4]]}},"alternative-id":["10.1080\/03007995.2026.2676335"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2026.2676335","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-02-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}